Aryzta (ARYN.SW) traded down -0.6 % during a 24 hours period ending at 03:27 PM Central Europe on Monday 26th. One Aryzta stock can currently be bought for about CHF 41.85 on popular exchanges. Current supply of Aryzta stocks is 24.8 mn. Aryzta has a current market capitalization of CHF 1 bn and approximately CHF 3.3 mn worth of Aryzta was traded on exchanges in the last 24 hours. Since last month end, Aryzta has traded 12.93 % up. Simple moving average of last 200 days is at CHF 52.46. The highest price of past 52 weeks was recorded at CHF 64.7 on 04/10/2026. 52 weeks low was at CHF 35.9 on 09/21/2026.

Summary of the latest news for Aryzta

ARYZTA AG announced a series of measures aimed at strengthening its performance in Germany and highlighted the completion of a second French bolt‑on acquisition. The company, which holds a leading position in the convenience bakery sector, also issued guidance for the end of 2026. The statement, released under the Swiss Code of Obligations, reaffirmed ARYZTA’s commitment to restructuring its operations and expanding its European footprint. The company’s board noted that the new acquisition aligns with its strategy to consolidate market presence and enhance operational efficiency. No specific financial figures were disclosed, but the announcement suggests a focus on improving profitability and market share through targeted acquisitions and regional initiatives.

Here is how related stocks have performed in the past 24 hours:

  • Interroll (INRN.SW) traded down -0.58 % and now trades at CHF 1,408. Current market capitalisation for Interroll is CHF 1.2 bn. Interroll has a current price to earnings ratio of 21.23.

  • Forbo (FORN.SW) traded up 0.47 % and now trades at CHF 882. Forbo has a market capitalisation of CHF 1.2 bn. Forbo has a current price to earnings ratio of 18.27.

  • Naturenergie (NEAG.SW) traded down -0.68 % and now trades at CHF 28.9. Current market capitalisation for Naturenergie is CHF 961.3 mn. Current price/earnings ratio for Naturenergie is 6.41.

  • Implenia (IMPN.SW) traded up 0.8 % and now trades at CHF 63.4. Implenia has a market capitalisation of CHF 1.2 bn. Current price/earnings ratio for Implenia is 13.74.

  • Idorsia (IDIA.SW) traded down -1.13 % and now trades at CHF 4.3. Idorsia has a market capitalisation of CHF 1.1 bn. Idorsia Ltd, listed on the SIX Swiss Exchange, announced a new development program for its dual orexin‑receptor antagonist daridorexant, focusing on autism spectrum disorder (ASD). The decision follows a Phase‑2 study in children with insomnia that revealed unexpected improvements in affect, cognition and daily activities among participants with ASD or subthreshold ASD characteristics. Idorsia plans to pursue a dedicated formulation and discuss program design with global health authorities, with further details expected in the first half of 2027. The company highlighted the potential therapeutic relevance of orexin signaling in ASD, citing emerging scientific evidence that supports the pathway’s role in social interaction, behavior and attention. Meanwhile, the Swiss market saw Idorsia’s shares rise in the SIX index, reflecting broader positive movement in the sector, although the company’s stock remained among the stronger performers in the index for the day.

About Aryzta

Aryz AG is a Swiss-based company that specializes in producing and retailing a diverse range of bakery products. The company produces French and continental breads, pastries, confections, lunches, cookies, pizza, appetizers, and sweet baked goods. Aryz operates globally in regions including North America, South America, Europe, South East Asia, Australia, and New Zealand. You can learn more about their offerings by visiting their website at www.aryz.com , and they are traded on the SIX Swiss Exchange.